Literature DB >> 21518958

Kinase suppressor of ras 1 (KSR1) regulates PGC1α and estrogen-related receptor α to promote oncogenic Ras-dependent anchorage-independent growth.

Kurt W Fisher1, Binita Das, Robert L Kortum, Oleg V Chaika, Robert E Lewis.   

Abstract

Kinase suppressor of ras 1 (KSR1) is a molecular scaffold of the Raf/MEK/extracellular signal-regulated kinase (ERK) cascade that enhances oncogenic Ras signaling. Here we show KSR1-dependent, but ERK-independent, regulation of metabolic capacity is mediated through the expression of peroxisome proliferator-activated receptor gamma coactivator 1α (PGC1α) and estrogen-related receptor α (ERRα). This KSR1-regulated pathway is essential for the transformation of cells by oncogenic Ras. In mouse embryo fibroblasts (MEFs) expressing H-Ras(V12), ectopic PGC1α was sufficient to rescue ERRα expression, metabolic capacity, and anchorage-independent growth in the absence of KSR1. The ability of PGC1α to promote anchorage-independent growth required interaction with ERRα, and treatment with an inhibitor of ERRα impeded anchorage-independent growth. In contrast to PGC1α, the expression of constitutively active ERRα (CA-ERRα) was sufficient to enhance metabolic capacity but not anchorage-independent growth in the absence of KSR1. These data reveal KSR1-dependent control of PGC1α- and ERRα-dependent pathways that are necessary and sufficient for signaling by oncogenic H-Ras(V12) to regulate metabolism and anchorage-independent growth, providing novel targets for therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21518958      PMCID: PMC3133429          DOI: 10.1128/MCB.05255-11

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  78 in total

1.  The orphan nuclear receptor estrogen-related receptor alpha is a transcriptional regulator of the human medium-chain acyl coenzyme A dehydrogenase gene.

Authors:  R Sladek; J A Bader; V Giguère
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  KSR stimulates Raf-1 activity in a kinase-independent manner.

Authors:  N R Michaud; M Therrien; A Cacace; L C Edsall; S Spiegel; G M Rubin; D K Morrison
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

3.  Estrogen-related receptor alpha 1 functionally binds as a monomer to extended half-site sequences including ones contained within estrogen-response elements.

Authors:  S D Johnston; X Liu; F Zuo; T L Eisenbraun; S R Wiley; R J Kraus; J E Mertz
Journal:  Mol Endocrinol       Date:  1997-03

4.  Identification of a selective inverse agonist for the orphan nuclear receptor estrogen-related receptor alpha.

Authors:  Brett B Busch; William C Stevens; Richard Martin; Peter Ordentlich; Sihong Zhou; Douglas W Sapp; Robert A Horlick; Raju Mohan
Journal:  J Med Chem       Date:  2004-11-04       Impact factor: 7.446

5.  Erralpha and Gabpa/b specify PGC-1alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle.

Authors:  Vamsi K Mootha; Christoph Handschin; Dan Arlow; Xiaohui Xie; Julie St Pierre; Smita Sihag; Wenli Yang; David Altshuler; Pere Puigserver; Nick Patterson; Patricia J Willy; Ira G Schulman; Richard A Heyman; Eric S Lander; Bruce M Spiegelman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-20       Impact factor: 11.205

6.  The orphan receptors NGFI-B and steroidogenic factor 1 establish monomer binding as a third paradigm of nuclear receptor-DNA interaction.

Authors:  T E Wilson; T J Fahrner; J Milbrandt
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

7.  KSR, a novel protein kinase required for RAS signal transduction.

Authors:  M Therrien; H C Chang; N M Solomon; F D Karim; D A Wassarman; G M Rubin
Journal:  Cell       Date:  1995-12-15       Impact factor: 41.582

8.  Activation of antioxidant pathways in ras-mediated oncogenic transformation of human surface ovarian epithelial cells revealed by functional proteomics and mass spectrometry.

Authors:  Travis W Young; Fang C Mei; Gong Yang; Jennifer A Thompson-Lanza; Jinsong Liu; Xiaodong Cheng
Journal:  Cancer Res       Date:  2004-07-01       Impact factor: 12.701

9.  Regulation of PPARgamma coactivator 1alpha (PGC-1alpha) signaling by an estrogen-related receptor alpha (ERRalpha) ligand.

Authors:  Patricia J Willy; Ian R Murray; Jing Qian; Brett B Busch; William C Stevens; Richard Martin; Raju Mohan; Sihong Zhou; Peter Ordentlich; Ping Wei; Douglas W Sapp; Robert A Horlick; Richard A Heyman; Ira G Schulman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-07       Impact factor: 11.205

10.  Increased OXPHOS activity precedes rise in glycolytic rate in H-RasV12/E1A transformed fibroblasts that develop a Warburg phenotype.

Authors:  Ad J C de Groof; Mariska M te Lindert; Michiel M T van Dommelen; Min Wu; Marieke Willemse; Amy L Smift; Mike Winer; Frank Oerlemans; Helma Pluk; Jack A M Fransen; Bé Wieringa
Journal:  Mol Cancer       Date:  2009-07-31       Impact factor: 27.401

View more
  22 in total

Review 1.  The diverse role of the PPARγ coactivator 1 family of transcriptional coactivators in cancer.

Authors:  Geoffrey D Girnun
Journal:  Semin Cell Dev Biol       Date:  2012-01-21       Impact factor: 7.727

Review 2.  The master role of microphthalmia-associated transcription factor in melanocyte and melanoma biology.

Authors:  Akinori Kawakami; David E Fisher
Journal:  Lab Invest       Date:  2017-03-06       Impact factor: 5.662

3.  KSR1 and EPHB4 Regulate Myc and PGC1β To Promote Survival of Human Colon Tumors.

Authors:  Jamie L McCall; Drew Gehring; Beth K Clymer; Kurt W Fisher; Binita Das; David L Kelly; Hyunseok Kim; Michael A White; Robert E Lewis
Journal:  Mol Cell Biol       Date:  2016-08-12       Impact factor: 4.272

4.  MicroRNA-125a reduces proliferation and invasion of oral squamous cell carcinoma cells by targeting estrogen-related receptor α: implications for cancer therapeutics.

Authors:  Ankana Tiwari; Swamy Shivananda; Kodaganur S Gopinath; Arun Kumar
Journal:  J Biol Chem       Date:  2014-09-29       Impact factor: 5.157

5.  Kinase suppressor of Ras 2 (KSR2) regulates tumor cell transformation via AMPK.

Authors:  Mario R Fernandez; MaLinda D Henry; Robert E Lewis
Journal:  Mol Cell Biol       Date:  2012-07-16       Impact factor: 4.272

6.  PGC1α promotes tumor growth by inducing gene expression programs supporting lipogenesis.

Authors:  Kavita Bhalla; Bor Jang Hwang; Ruby E Dewi; Lihui Ou; William Twaddel; Hong-Bin Fang; Scott B Vafai; Francesca Vazquez; Pere Puigserver; Laszlo Boros; Geoffrey D Girnun
Journal:  Cancer Res       Date:  2011-09-13       Impact factor: 12.701

Review 7.  KSR as a therapeutic target for Ras-dependent cancers.

Authors:  Beth K Neilsen; Danielle E Frodyma; Robert E Lewis; Kurt W Fisher
Journal:  Expert Opin Ther Targets       Date:  2017-04-07       Impact factor: 6.902

8.  AMPK Promotes Aberrant PGC1β Expression To Support Human Colon Tumor Cell Survival.

Authors:  Kurt W Fisher; Binita Das; Hyun Seok Kim; Beth K Clymer; Drew Gehring; Deandra R Smith; Diane L Costanzo-Garvey; Mario R Fernandez; Michael G Brattain; David L Kelly; John MacMillan; Michael A White; Robert E Lewis
Journal:  Mol Cell Biol       Date:  2015-09-08       Impact factor: 4.272

9.  Caveolin-1 is required for kinase suppressor of Ras 1 (KSR1)-mediated extracellular signal-regulated kinase 1/2 activation, H-RasV12-induced senescence, and transformation.

Authors:  Robert L Kortum; Mario R Fernandez; Diane L Costanzo-Garvey; Heidi J Johnson; Kurt W Fisher; Deanna J Volle; Robert E Lewis
Journal:  Mol Cell Biol       Date:  2014-07-07       Impact factor: 4.272

10.  Genetic variants of kinase suppressors of Ras (KSR1) to predict survival in patients with ERα-positive advanced breast cancer.

Authors:  L Benhaim; W Zhang; T Wakatsuki; D Yang; A Gerger; P Bohanes; D Paez; F Loupakis; M J LaBonte; Y Ning; R El-Khoueiry; R Ladner; P Wilson; H Zhang; G Giamas; J Stebbing; H J Lenz
Journal:  Pharmacogenomics J       Date:  2014-10-07       Impact factor: 3.550

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.